학술논문
Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study
Document Type
Article
Author
Gaspar, Nathalie ; Venkatramani, Rajkumar; Hecker-Nolting, Stefanie; Melcon, Soledad Gallego; Locatelli, Franco; Bautista, Francisco; Longhi, Alessandra; Lervat, Cyril; Entz-Werle, Natacha; Casanova, Michela; Aerts, Isabelle; Strauss, Sandra J; Thebaud, Estelle; Morland, Bruce; Nieto, Adela Cañete; Marec-Berard, Perrine; Gambart, Marion; Rossig, Claudia; Okpara, Chinyere E; He, Cixin; Dutta, Lea; Campbell-Hewson, Quentin
Source
In The Lancet Oncology September 2021 22(9):1312-1321
Subject
Language
ISSN
1470-2045